Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- SBS.F
- Price
- 23.90
- Stock movement down
- -0.70 (-2.85%)
- Company name
- Stratec SE
- Exchange
- (F ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Devices
- Market cap
- 290.53M
- Ent value
- 480.50M
- Price/Sales
- 1.16
- Price/Book
- 1.28
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- 0.01%
- Trailing P/E
- 29.02
- Forward P/E
- 12.87
- PEG
- -
- EPS growth
- 7.48%
- 1 year return
- -35.92%
- 3 year return
- -40.42%
- 5 year return
- -23.09%
- 10 year return
- -6.08%
Last updated: 2025-04-05
DIVIDENDS
SBS.F does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 29.02 |
| Price to OCF | 8.51 |
| Price to FCF | 15.82 |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 1.16 |
| Price to Book | 1.28 |
| EV to Sales | 1.92 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 12.16M |
| EPS (TTM) | 0.82 |
| FCF per share (TTM) | 1.51 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 250.54M |
| Gross profit (TTM) | 67.75M |
| Operating income (TTM) | 22.09M |
| Net income (TTM) | 10.01M |
| EPS (TTM) | 0.82 |
| EPS (1y forward) | 1.86 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 27.04% |
| Operating margin (TTM) | 8.82% |
| Profit margin (TTM) | 4.00% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 33.11M |
| Net receivables | 38.55M |
| Total current assets | 235.49M |
| Goodwill | 50.16M |
| Intangible assets | 63.37M |
| Property, plant and equipment | 81.63M |
| Total assets | 450.84M |
| Accounts payable | 13.10M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 93.36M |
| Total liabilities | 223.08M |
| Shareholder's equity | 227.76M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 34.15M |
| Capital expenditures (TTM) | 15.78M |
| Free cash flow (TTM) | 18.37M |
| Dividends paid (TTM) | 1.00K |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 4.40% |
| Return on Assets | 2.22% |
| Return on Invested Capital | 4.40% |
| Cash Return on Invested Capital | 8.06% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 23.15 |
| Daily high | 23.90 |
| Daily low | 23.15 |
| Daily Volume | 0K |
| All-time high | 145.20 |
| 1y analyst estimate | 41.00 |
| Beta | 0.23 |
| EPS (TTM) | 0.82 |
| Dividend per share | - |
| Ex-div date | 20 May 2024 |
| Next earnings date | 16 May 2025 |
Downside potential
Loading...
Downside potential data
| SBS.F | S&P500 | |
| Current price drop from All-time high | -83.54% | -12.44% |
| Highest price drop | -97.63% | -56.47% |
| Date of highest drop | 24 Oct 2002 | 9 Mar 2009 |
| Avg drop from high | -61.51% | -11.07% |
| Avg time to new high | 254 days | 12 days |
| Max time to new high | 5158 days | 1805 days |
COMPANY DETAILS
Marketcap
290.53M
Marketcap category
Small-cap
Description
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Employees
1462
Website
Investor relations
-
SEC filings
CEO
Country
Germany
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Amidst a backdrop of economic uncertainty and inflationary pressures, European markets have faced challenges with the recent imposition of U.S. trade tariffs impacting investor sentiment. Despite thes...
April 4, 2025
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...
March 25, 2025
As the pan-European STOXX Europe 600 Index continues its streak of weekly gains, buoyed by encouraging company results and resilience amidst global trade uncertainties, investors are increasingly focu...
March 7, 2025
As the European market experiences a mixed economic landscape, with the pan-European STOXX Europe 600 Index showing resilience amidst global uncertainties, investors are increasingly focusing on growt...
March 6, 2025
Key Insights Given the large stake in the stock by institutions, Stratec's stock price might be vulnerable to their...
February 20, 2025
As global markets rally with U.S. stocks reaching record highs, driven by optimism around AI advancements and potential trade resolutions, growth stocks have notably outperformed their value counterpa...
January 31, 2025
As global markets experience a wave of optimism driven by hopes for softer tariffs and enthusiasm surrounding artificial intelligence, major indices like the S&P 500 have reached record highs. Amidst ...
January 29, 2025
It is hard to get excited after looking at Stratec's (ETR:SBS) recent performance, when its stock has declined 22% over...
January 18, 2025
As global markets navigate a mixed landscape marked by fluctuating consumer confidence and economic data, major U.S. stock indexes have shown moderate gains, particularly driven by large-cap growth st...
January 1, 2025
In a week marked by cautious commentary from the Federal Reserve and political uncertainty, global markets experienced notable declines, with U.S. indices such as the S&P 500 and Dow Jones Industrial ...
December 27, 2024
Next page